Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 233 M260 M270 M289 M 1.05 B Research & development ———— — Operating income 311 M296 M389 M372 M 1.37 B Non-Operating Income, Total 6 M23 M-10 M2 M 21 M Interest expense, net of interest capitalized 51 M52 M58 M54 M 215 M Non-Operating Income, excl. Interest Expenses -38 M-42 M-43 M-41 M -164 M Unusual income/expense -7 M13 M-25 M-11 M -30 M Pretax income 246 M262 M320 M1.14 B 1.97 B Equity in earnings -20 M-5 M-1 M-5 M -31 M Taxes 54 M63 M81 M65 M 263 M Non-controlling/minority interest ———0 — After tax other income/expense ———— — Net income before discontinued operations 192 M199 M239 M250 M 880 M Discontinued operations ———0 — Net income 192 M199 M239 M250 M 880 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 192 M199 M239 M250 M 880 M Basic earnings per share (Basic EPS) 0.510.530.650.68 2.37 Diluted earnings per share (Diluted EPS) 0.50.520.640.67 2.33 Average basic shares outstanding 374 M374 M369 M371 M — Diluted shares outstanding 381 M380 M376 M378 M — EBITDA 662 M679 M759 M783 M 2.88 B EBIT 520 M523 M624 M600 M 2.27 B Cost of revenue 5.99 B6.18 B6.37 B6.75 B 25.29 B Other cost of goods sold 1.32 B1.44 B1.44 B— — Depreciation & amortization (cash flow) 142 M156 M135 M183 M 616 M